August 6, 2021
E43: Innovative venture strategies, Zymergen's implosion, Square acquires Afterpay & more
-
David Friedberg’s Production Board raised $300 million after four years operating as a permanent holding company rather than a conventional venture fund. Alphabet became a minority shareholder with a board seat, while new institutional capital lets TPB fund deep-tech companies until commercialization instead of forcing premature outside rounds.
-
David Sacks raised Craft Ventures’ third fund to $1.12 billion—$612 million for venture and $510 million for growth—while narrowing the firm to SaaS and marketplaces. His incubated audio startup Callin drew roughly 900 requests totaling $7 million for a $1 million syndicate allocation before leaving private beta.
-
Chamath Palihapitiya argued that giant venture firms increasingly win by moving capital quickly, not merely by maximizing returns on each individual deal. Large LPs may prefer $50 million checks and need only mid-single-digit returns, encouraging branded firms to deploy funds rapidly, collect management fees and return for larger pools.
-
Zymergen’s collapse was preceded by years without clear product-market fit, first as a services business and then as a products company. After taking $400 million from SoftBank at a $3 billion valuation and going public, it said 2021 product revenue would disappear, 2022 revenue would be immaterial, and its stock fell about 70%.
-
The people most exposed to Zymergen’s collapse included employees who exercised options before the IPO and could owe taxes on gains that later vanished. Friedberg said some bought shares at low strike prices, incurred tax liabilities based on much higher fair values, then faced an $8 stock they could not sell during lockup.
-
Jason Calacanis said 20–30% of apparently attractive startup deals failed his syndicate’s basic diligence once researchers checked cap tables, revenue, accounting, bank statements, incorporation records and IP assignments. He cited hidden founder loans and revenue presentations that changed materially under scrutiny, arguing that ordinary verification catches problems polished pitches conceal.
-
Chamath said a senior executive he knew received a Theranos offer without being allowed past reception, meeting the team or seeing the device. For him, that secrecy—combined with a board heavy on elderly statesmen rather than diagnostics experts—was enough to warn him away.
-
Square’s roughly $30 billion Afterpay acquisition was presented as a bet that buy-now-pay-later is a feature inside a broader financial platform, not a durable standalone category. The speakers argued that banking, lending, trading, crypto and insurance are converging, with banking licenses and cheaper capital likely to determine which digital firms can consolidate the stack.